Channel News AsiaCelladon says heart treatment fails in trialChannel News AsiaCelladon Corp said its heart failure gene therapy Mydicar failed to meet its primary and secondary endpoints in an important trial. PHOTOS. Photo illustration shows a lab technician looking through a microscope. (AFP File/Getty Images - Joe Raedle). Enlarge ...and more »
